Specialty Pharmacy

Enfortumab vedotin-ejfv (Padcev) elicited durable responses in patients with locally advanced or metastatic urothelial cancer who received previous treatment with a PD-1/PD-L1 inhibitor.

The authors concluded that a single dose of targeted intraoperative radiotherapy should be an option accessible to health care providers and discussed with patients.

On Women Pharmacists Day, 5 industry leaders discuss work-life balance, job advancement, and mentorship.

Several risk factors for multiple sclerosis, such as disease progression and fatigue, increase the risk of unemployment.

Bacteria in the gut may play a role in the treatment outcomes of patients with prostate cancer taking oral medications, according to a recent study.

To celebrate American Pharmacists Month, Pharmacy Times spoke with several pharmacists about their experiences during the COVID-19 pandemic and how they have tackled its unique challenges.

Specialty pharmacies are uniquely positioned to thrive in the era of value-based health care.

During American Pharmacists Month, and as the country uses all available health care resources to address COVID-19, there has never been a better or more important time to grant provider status to pharmacists.

Study findings align with recent recommendations from the National Comprehensive Cancer Network for preventing febrile neutropenia in patients with early-stage breast cancer.

An overview of arrangements that pharmacies enter into that violate the federal anti-kickback statute.

Partnership will commemorate the event with a webinar and presentation of Woman Pharmacist of the Year award on Oct. 12.

Like diabetes, Inflammatory bowel disease may also be linked to a high-fructose diet.

IMGN632 granted breakthrough designation for the treatment of patients with relapsed or refractory blastic plasmacytoid dendritic cell neoplasm.

Integrating specialty pharmacy staff into oncology, neurology, rheumatology, and other specialty clinics within their health systems is a growing trend with a range of beneficial outcomes.

Nivolumab plus ipilimumab is the first immunotherapy approved for previously untreated unresectable malignant pleural mesothelioma.

During American Pharmacists Month, the National Association of Chain Drug Stores is honoring the role of pharmacists as the most accessible point of health care for patients, particularly among those in the greatest need.

Pharmacy Times will be celebrating pharmacists throughout the month of October to recognize their contributions to the health care field, especially in the ongoing coronavirus disease 2019 pandemic.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

The FDA has approved golimumab for the treatment of patients 2 years of age and older with active polyarticular juvenile idiopathic arthritis.

Intravenous Immunoglobulin helps to improve hypoxia, which can reduce the need for mechanical ventilation.

The results of an additional secondary endpoint from the phase 3 HERO study evaluating oral relugolix in men with advanced prostate cancer showed that relugolix had a similar rate of castration resistance-free survival compared to intravenous leuprolide acetate in men with metastatic disease through 48 weeks.

The FDA has approved mepolizumab for the treatment of hypereosinophilic syndrome.

Pregnancy may help put off the onset of multiple sclerosis symptoms by more than 3 years.

Using a 3D model, investigators found a soy-based compound was effective in treating bone cancer.

At ESMO 2020, researchers discussed some long-awaited data regarding postoperative radiotherapy used in patients with non-small cell lung cancer following complete resection and after (neo) adjuvant chemotherapy.

New drug application been submitted for TLX591-CDx (illumet), a radiopharmaceutical product that targets prostate-specific membrane antigen for the imaging of prostate cancer.

Among patients with cervical cancer, there was no significant difference found between the risk of recurrence, local recurrence, or death among individuals who either completed or abandoned a radical uterine procedure following the intraoperative detection of a positive pelvic lymph node.

Top news of the week from Pharmacy Times®.

The FDA has granted fast track designation to DKN-01 for the treatment of patients with gastric and gastroesophageal junction adenocarcinoma whose tumors have high DKK1 expression.

An overview of the most common human resources problems that pharmacies face and the proactive steps that pharmacies can take to avoid these problems.